Biosimulation Market to Witness the Highest Growth During The Forecast Period To 2020


Posted May 22, 2017 by dheerajshaha67

The biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, at a CAGR of 15.29%.

 
The report “Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by Application (Drug Discovery & Development, Preclinical, Clinical Trial), by End Users - Global Forecast to 2020”, provides a detailed overview of the major drivers, restraints, and opportunities impacting the global biosimulation market along with the estimates and forecasts of the revenue and market share analysis.

The biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, at a CAGR of 15.29%.

Browse 75 market data tables and 64 figures spread through 150 pages and in-depth TOC on “Biosimulation Market”

http://www.marketsandmarkets.com/Market-Reports/biosimulation-market-838.html

Industry Insights:
In this report, the global biosimulation market is segmented based on product, application, end user, and geography. By product, the market includes software and services. The software segment includes molecular modeling and simulation software, PBPK modeling and simulation software, PK/PD modeling and simulation software, trail design software, toxicity prediction software, and other software (QSP, visualizing and analytical software). The services segment includes in-house services and external/contract services.
Based on applications, the market is segmented into drug discovery, drug development, and others (defense, industrial bioprocessing, nutraceuticals, and agri-food production). The drug development application segment is further classified into preclinical testing and clinical trials. The drug discovery segment is divided into target identification & validation and lead identification & optimization.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=838

The major drivers for the biosimulation market include the strong trend of R&D investments in biotechnology and pharmaceutical industries; the need to curtail drug discovery & development costs; growth in the biologics and biosimilars market; increased use of personalized medicines; technological advancements; and the trend of periodic product upgradation.

Scope of the Report:
This report categorizes the global market into the following segments:
• Global Market, by Product
• Global Market, by Application
• Global Market, by End User
• Global Market, by Geography

Request a sample of the report:
http://www.marketsandmarkets.com/requestsample.asp?id=838

Industry Leaders:
The major players in the global biosimulation market are Certara USA, Inc. (U.S.), Simulation Plus Inc. (U.S.), Dassault Systèmes SA (France), Schrödinger Inc. (U.S.), Advanced Chemistry Development, Inc. (Canada), Chemical Computing Group, Inc. (Canada), Physiomics PLC (U.K.), Entelos Holding Corporation (U.S.), Rhenovia Pharma Ltd. (France), and Genedata AG (Switzerland).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: [email protected]
Tel: 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By D Shaha
Country India
Categories Business , Health , Industry
Tags biosimulation , biosimulation market
Last Updated May 22, 2017